
Sign up to save your podcasts
Or
Not that long ago psychedelics were considered dangerous, and only enjoyed recreationally by a fringe element of society. Today, researchers are looking at drugs like psilocybin to develop treatments for depression, PTSD, addiction, and anxiety. This episode features guests steeped in the world of psychedelics who are finding new ways to treat mental health.
Guests:
Dr. Frank Wiegand, Chief Medical Officer, Beckley Psytech
Kurt Rasmussen, Ph.D., Chief Scientific Officer, Delix Therapeutics
Clara Burtenshaw, Co-founder and Partner, Neo Kuma Ventures
4.9
8383 ratings
Not that long ago psychedelics were considered dangerous, and only enjoyed recreationally by a fringe element of society. Today, researchers are looking at drugs like psilocybin to develop treatments for depression, PTSD, addiction, and anxiety. This episode features guests steeped in the world of psychedelics who are finding new ways to treat mental health.
Guests:
Dr. Frank Wiegand, Chief Medical Officer, Beckley Psytech
Kurt Rasmussen, Ph.D., Chief Scientific Officer, Delix Therapeutics
Clara Burtenshaw, Co-founder and Partner, Neo Kuma Ventures
6,133 Listeners
941 Listeners
461 Listeners
756 Listeners
811 Listeners
2,052 Listeners
309 Listeners
122 Listeners
318 Listeners
59 Listeners
147 Listeners